4A - Colon Cancer Instructions Describe the biological and physiological aspects of colon cancer and potential chemical treatments or pathways that are affected.Discuss the natural progression of colo

*************** ********** of ******************* ** Affiliation:          IntroductionThe ***** ** an essential ***** ** *** digestive ***** ** ** part ** the large ********* ******* ******* *** ****** *** *** ***** ********* ********** ** ***** mineral *** ********* ** well as ******* of ** ***** ******** ***** **** ** *** ***** ** *** ***** *** ***** *** four ******** namely *** ********** ***** ********* ***** sigmoid ***** ** **** as the ********** ***** *** biological ****** ** the ***** leads ** **** ******** ************ ** the ********** Physiologically *** colon *** **** ******** to **** ****** *** ******* pathologies **** as ****** ***** cancer ** * **** ** **************** ****** that ******** *** multifactorial ******* ******* *** etiology ** *** ******* encompasses ******* factors *** *********** as **** ** ************ ********** ******* ** ** ***** **** ********** ****** *** ********** **** a ******** **** ** colon cancer with potential ******** ***** death ** recoveryDiscussionBiologically *** disease ******** ******* ******* and ********** *********** which ********** **** the normal ******* ********** to colonic ************** *** genetic *** ********** modifications **** to colon ****** formation ** ***** ** * ****** growth ********* ** *** affected ***** Cancer *** **** ****** ******* a ********** *********** ** either the molecular ** ************* ***** *** other ******** ******* which colon ****** *** ******* ** **** *** ****** ******** *********** to *** germline ** *** ******* ******* ***** ***** ******* somatic cases This leads ** the development ** sporadic colon ******* *** ************* ****** ** *** ***** *** a ******** ******* **** **** as * ******* *** regulation ** morphogenesis ****** ******* ** **** ** development ********** ** cancer is ******* metastasis and infiltration *** rupture ** the intercellular ********* ** ******* *** *********** ******** ** the proteases ******* et al 2018) The ************* processes through proteolytic ******** ******* *** ********** ** the ************* ****** **** ** fibronectins ********* ** well ** ********* ***** on the ********* chemical ********** and ******** ******** ********* **** there is ** increasing ********* ** the disease There is *** *********** ** ********** has led ** adjuvant ********** that help ** *** *********** ** the cancer cells *** ******** **** *********** **** * **** ********* of *** cancer **** ***** and **** leads ** pathways that *** ********** ******** The **** ** to block ***** ****** Patients with ********** **** multiple tumors Findings postulate **** ***** **** of colon ****** ** **** in patients *** ******* in **** II ******** Since ** ** * significant ******* *** ********* of colon ****** ** ****** *** ****** ****** reports *** ******* ****** of ****** *** ***** of colon ****** ******** *** *** ** mutations **** ***** ** the ********** ****** of the ********* *** symptoms ** colon ****** are *** numerous ** ***** ** develop **** time and ********* when *** disease ****** ** **** **** **** & *** 2017) Adjuvant ************ ****** *** ** * combination ** ********* *** *** surgery ********* *********** *** progress ** ********** cancer *** be ******* *** adenoma-carcinoma ******** *** ******** polyp ********* ******** as well ** *** ********* ********* ******** ******* it ****** **** *** ********* ****** as **** ** *** *********** ***** ***** ******** ** *** ********** ***** This ** ********* ** ******************* to form **** ** ****** as *** ***** dysplasia An alteration ** the suppressor genes accompanies the progress ** *** ********* ****** to ***** ****** and *** ******* **** **** abnormalities ** **** ********** ********* *** development ** colon cancer *** be based on ******* ********** ** **** ** the ************* factors *** ******** ** ****** ** ********* by *** ********* ************** ** well ** *** ************* factors **** **** ** ****** ****** ** *** large ********* common ** ****** ****** *** ********** ** ** *** age It ****** as * ************ ** ***** **** **** ** *** **** of *** colon *** ***** ******* ** become cancerous *** polyps ***** **** **** ** the **** *** small *** produce ******** ** ***** ****** *** ****** **** **** on *** ***** ******* ** the colon ******* et ** ***** *** rapid *********** of *** ***** ***** ** ********* *********** ****** ******** **** ****** **** ***** cancer *** ****** ******** or ***** *** **** *** *** *** **** ********* ********** *** reduce the chances ** ********** ******** ******** **** ***** *** **** effective ********** **** can **** ** ******** Advanced approaches ** **** ** technologies have **** ******** ** ******* *** ********** numbers **** **** **** ******** ****** ************* **** ********** the treatment ******* *** **** ** diagnosing *** ******* *** provision ** a ************* as **** ** treatment **** *** **** ** *** recovery process ******* ******** **** therapy ******** can **** ** recovery **** of *** therapy ******** **** are ******** in health care ***** **** ************* ************ as well ** ************ ********** care ******** *** **** ** offered ********* ** the ********* ****** treatment mechanisms can ****** *** ******* of ****** ******* recovery ******* on *** ********* ********** ******* to ******* *** ******** ****** ** ******* *** ******* ***** *** lead ** ******** ***** Since *** development ** from the ****** colonic ****** via *** *********** ***** ********* ** later leads to ***** ****** ***** on *** ******** of *** disease ***** ********* ******** *** ** **** ** ** ************ ******* ***** et al ***** ******* ********* *** **** ********* *** ***** ** ***** ****** *** **** ***** ** ********* ** *** **** ** ********* to ** ************************ to control *** ******* ***** ** ***** *********** evidence ********* **** ****** * ******* ** the US ********** die ******** *** ** ***** ****** ***** screening can **** ****** *** ******** *** ****** of *** ******* ** ** ********** ** ** *** ** the leading ****** ** ***** in *** ****** ****** *** ******** ** the ****** ** ***** ** ********** to *** ********* ******* ********* ******* **** **** **** ********** ** ***** ****** ******** The ********** ** ****** ********* ******** can reduce the risks ** ****** at ******* **** ********* for colon ****** is ***** ** *** ***** ** spread **** there is * **** for recovery ******** before ** ******* *** ******** *********************************************** * B ****** A P Al-Hawary * M ********** L **** Y * ******* * K ***** ************** * (2018) **** ********** insights: colon ****** version 22018 ******* ** *** ******** ************* ****** ******* 16(4) ********** * * **** * & *** * ****** Adjuvant Chemotherapy of ***** Cancer—Histology vs ******* ** ***************** Management ** **************** ******* *** ************ J * Watt D G ******** * * ****** P G ***** ******** D C ****** ********** ****** systemic ************ *** ******* ****** ** Surgery ****** ************* R * ***** * ****** R C ******* * ** * ***** ******* * * ****** An ********** ** ******** ** ****** ******* CA: * ****** journal *** ********** ***** *********************

Click here to download attached files: Colon Cancer Paper.docx